Akums Drugs and Pharmaceuticals has started FY27 on a strong note, with Q1 profit surging 55 percent year-on-year.
The latest developments highlight CDMO deals, Q1 earnings, and AI medtech transformation as key drivers shaping the pharmaceutical sector
India’s healthcare sector saw major funding, partnerships, investments, expansion plans, and pharma developments this week. KKR moved to acquire Medicover India in a USD 1.5 billion healthcare deal. Cipla and Rocket India announced...
Clinical innovation drives a new wave of transformation as companies expand biosimilars portfolios, regulators strengthen drug quality frameworks
Medical device manufacturing in India is set to enter a new shift as the government strengthens its push to build an export-oriented ecosystem
Skin cancer continues to challenge global healthcare systems as cases rise and treatment gaps persist. But a recent USFDA approval has introduced new hope in skin cancer treatment
Global health concern intensifies as the latest Salmonella outbreak in the United States exposes the growing risks linked to foodborne infections
Drug research in India is undergoing a major shift as the government accelerates support for non-animal testing methods
Ebola outbreak conditions worsen in Congo as confirmed infections cross 4,000, marked as one of the most severe health emergencies
Pharma regulation reform, cancer care access, and drug safety drive the latest developments in the pharmaceutical sector, as policymakers and companies have accelerated structural changes and healthcare outreach
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")